From: Monitoring prescribing patterns using regression and electronic health records
 | A2Blocker | ACE | Beta_Blocker | Cal_Chan | Thiazide | Percent of patients |
---|---|---|---|---|---|---|
Asthma | 0.018 | −0.014 | −0.043 | 0.009 | 0.030 | 15.2 |
Bestrophinopathy | 0.391 | −0.248 | −0.081 | −0.120 | 0.058 | 1.7 |
Cardiomyopathies | −0.013 | 0.029 | 0.079 | −0.041 | −0.054 | 3.1 |
Chronic kidney disease stage 5 | −0.011 | −0.030 | 0.068 | 0.061 | −0.089 | 1.7 |
Congestive heart failure | 0.012 | 0.073 | 0.416 | −0.071 | −0.429 | 5.7 |
Coronary heart disease | −0.023 | −0.057 | 0.481 | −0.091 | −0.310 | 11.2 |
Diabetes mellitus | 0.101 | 0.261 | −0.042 | −0.122 | −0.197 | 45.7 |
Heart failure | 0.003 | −0.017 | 0.069 | 0.005 | −0.060 | 2 |
Hypertension induced by pregnancy | −0.017 | −0.037 | 0.044 | 0.047 | −0.038 | 0.5 |
Ischemia | −0.006 | −0.004 | 0.077 | −0.013 | −0.055 | 3.8 |
Kidney failure | −0.022 | −0.121 | 0.161 | 0.200 | −0.217 | 9.6 |
Renal insufficiency | −0.008 | −0.038 | 0.056 | 0.058 | −0.067 | 8.6 |
Tricuspid valve insufficiency | 0.000 | −0.001 | 0.004 | 0.001 | −0.004 | 3.7 |